Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
2.560
+0.140 (5.79%)
At close: Dec 19, 2025, 4:00 PM EST
2.520
-0.040 (-1.56%)
After-hours: Dec 19, 2025, 7:49 PM EST
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $120.65 million as of December 19, 2025. Its market cap has increased by 97.38% in one year.
Market Cap
120.65M
Enterprise Value
-41.95M
1-Year Change
97.38%
Ranking
Category
Stock Price
$2.56
Market Cap Chart
Since August 27, 2021, Whitehawk Therapeutics's market cap has decreased from $540.80M to $120.65M, a decrease of -77.69%. That is a compound annual growth rate of -29.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 114.05M | 46.67% |
| Dec 31, 2024 | 77.76M | 56.96% |
| Dec 29, 2023 | 49.54M | -84.17% |
| Dec 30, 2022 | 312.99M | -37.97% |
| Dec 31, 2021 | 504.59M | -6.70% |
| Aug 27, 2021 | 540.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.31B |
| Johnson & Johnson | 501.88B |
| AbbVie | 393.81B |
| UnitedHealth Group | 297.24B |
| AstraZeneca | 281.41B |
| Novartis AG | 260.53B |
| Merck & Co. | 249.91B |
| Abbott Laboratories | 217.56B |